Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SIM0692
- Development stage
- Phase 3
- Lead developer
- Jiangsu Simsheng Pharmaceutical
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Peptides
- Administration
- Subcutaneous
01
Overview
SIM0692 is a biosimilar candidate of romiplostim, a thrombopoietin (TPO) receptor agonist. Developed by Simcere (Shandong Simcere Biopharmaceutical), it is intended for the treatment of chronic immune thrombocytopenia (cITP). As a biosimilar of romiplostim (Romiplate), SIM0692 is a fusion protein consisting of an Fc domain linked to peptides that bind and activate the TPO receptor (MPL). This activation mimics the effect of endogenous thrombopoietin, stimulating the proliferation and differentiation of megakaryocytes in the bone marrow, thereby increasing platelet counts. The drug is currently undergoing Phase 1 clinical evaluation to demonstrate pharmacokinetic and pharmacodynamic bioequivalence to the reference product.
02
Targets
TPOR (Thrombopoietin receptor)
Beyond the preview
Go deeper on SIM0692.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SIM0692.